Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...
Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides Postmenopausal women, age 50-79 years, were entered on two randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results